Telemedicine electronic consenting preference among clinical trial participants.

03 medical and health sciences 0302 clinical medicine 16. Peace & justice 3. Good health
DOI: 10.1200/op.2023.19.11_suppl.516 Publication Date: 2023-10-26T13:03:34Z
ABSTRACT
516 Background: Telemedicine (TM) disparities in the US during pandemic are well-reported; however, its use by diverse participants providing electronic informed consent (eIC) for clinical trials oncology remains unexplored. Our previous research found eIC comparable to in-person paper-based visits across participants: stress, technology burden, comprehension, and agency complex genetic Phase I-II trial discussions. Based on this work, we hypothesized that our implementation of via TM would be well received, evaluated participant characteristics associated with their method preferences. Methods: Research clinic from Aug 2021- Jan 2023 received anonymous, uncompensated surveys electronically. We assessed age, sex, primary language, ethnicity, race, 3 groups survey questions generated factor analysis: 1) usability, 2) satisfaction 3) process comfort (comfort using eIC) (Table). A multivariable multinomial regression model associations between factors preference, a item assessing overall preference or no preference. Results: Among 1,154 respondents (28% response rate), 52% preferred eIC, 29% had 19% in-person. Respondent median age was 65; 51% were male; 97% English speaking; 6% Hispanic; 84% White, 7.7% Asian-Far East/Indian Subcontinent, 5.3% Black, 2.6% other. Non-native speakers (odds ratio (OR) 0.31; 95% confidence interval (CI) (0.1, 0.93), p=0.037) Black (OR 0.37; CI (0.16, 0.83), p=0.016) decreased odds preferring eIC. Similarly, increased 0.98; (0.96, 0.99), p=0.008) decrease compared Conclusions: Most However, adjusting comfort, satisfaction, other demographics, who older, non-native more likely prefer future will target these areas help support equitable consenting standards care.[Table: see text]
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....